Patients’ interest first, profit next
Guru Prasad Mohanta A cure for COVID-19 is most important. Japan, among others, is the latest to approve Remdesivir for use in severely ill COVID-19 patients. This is still an investigational drug and has not received approval for general use in any country. Earlier, the...











































